The binding of the YTHDF1 protein to m6A-modified TRIM29 promotes the translation of TRIM29 in cisplatin-resistant OC cells, enhances the cancer stem cell characteristics in cisplatin-resistant OC cells, and then promotes the development of malignant tumours. This evidence concerns the gene TRIM29 and cancer.